LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value of $180.38 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling Maturity, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $180.38M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $351.06M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $281.87M.
- 2025-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $136.78M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value |
|---|---|
| 2026-06-30 | $180.38M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $351.06M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $281.87M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $136.78M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $124.95M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $91.15M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $62.90M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $109.58M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $71.07M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $89.19M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $123.68M 10-Q · filed 2023-05-08 |
| 2022-09-30 | $8.46M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.27M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $10.01M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $76.09M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $58.05M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $77.98M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $121.61M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $414.90M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $400.63M 10-Q · filed 2020-05-08 |